<?xml version="1.0" encoding="UTF-8"?><mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="3.2" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd"><titleInfo><title>Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission</title></titleInfo><name><namePart>Hofhuis, W. (Ward)</namePart></name><name><namePart>Hop, W.C.J. (Wim)</namePart></name><name><namePart>Jongste, de J.C. (Johan)</namePart></name><name><namePart>Pijnenburg, M.W.H. (Mari&#235;lle)</namePart></name><subject lang="nl"><topic>Male</topic><topic>Child</topic><topic>Female</topic><topic>Humans</topic><topic>Research Support, Non-U.S. Gov&apos;t</topic><topic>Prospective Studies</topic><topic>Adolescent</topic><topic>Biological Markers/analysis</topic><topic>Recurrence</topic><topic>Regression Analysis</topic><topic>Breath Tests</topic><topic>Forced Expiratory Volume/physiology</topic><topic>Nitric Oxide/*analysis</topic><topic>Statistics, Nonparametric</topic><topic>Administration, Inhalation</topic><topic>Asthma/*diagnosis/physiopathology</topic><topic>Bronchodilator Agents/administration &amp; dosage</topic><topic>Budesonide/administration &amp; dosage</topic><topic>Vital Capacity/physiology</topic></subject><accessCondition></accessCondition><location><url>http://hdl.handle.net/1765/8477</url></location><language><languageTerm type="text">en</languageTerm></language><genre authority="local">journalArticle</genre><identifier type="issn">0040-6376</identifier><abstract>BACKGROUND: Nitric oxide in exhaled air (FE(NO)) is a marker of
      eosinophilic airway inflammation. A study was undertaken to determine
      whether FE(NO) predicts asthma relapse in asymptomatic asthmatic children
      in whom inhaled corticosteroids are discontinued. METHODS: Forty children
      (21 boys) of mean age 12.2 years on a median dose of 400 mug budesonide or
      equivalent (range 100-400) were included. FE(NO) was measured before and
      2, 4, 12, and 24 weeks after withdrawal of steroids. A relapse was defined
      as more than one exacerbation per month, or need for beta agonist
      treatment on 4 days per week for at least 2 weeks, or diurnal peak flow
      variability of &gt;20%. FE(NO) measurements were performed online with an
      expiratory flow of 50 ml/s. RESULTS: Nine patients relapsed. Two and 4
      weeks after withdrawal of steroids geometric mean FE(NO) in children who
      were about to relapse was higher than in those who did not relapse: 35.3
      ppb v 15.7 ppb at 2 weeks (ratio 2.3; 95% CI 1.2 to 4.1; p = 0.01) and
      40.8 ppb v 15.9 ppb at 4 weeks (ratio 2.6; 95% CI 1.3 to 5.1). An FE(NO)
      value of 49 ppb at 4 weeks after discontinuation of steroids had the best
      combination of sensitivity (71%) and specificity (93%) for asthma relapse.
      CONCLUSION: FE(NO) 2 and 4 weeks after discontinuation of steroids in
      asymptomatic asthmatic children may be an objective predictor of asthma
      relapse.</abstract><relatedItem type="host"><titleInfo><title>Thorax: an international journal of respiratory medicine</title></titleInfo><originInfo><dateIssued>2005-01-01</dateIssued>
</originInfo><identifier type="issn">0040-6376</identifier>
<identifier type="doi">urn:NBN:nl:ui:15-1765/8477</identifier>
<part><extent unit="page"></extent></part></relatedItem></mods>
